Abstract A cornerstone of HIV prevention clinical trials is providing a combination prevention package to all trial participants. The elements included in that standard of care (SoC) package evolve as new prevention modalities are developed. Pre-exposure prophylaxis (PrEP) was recommended by the World Health Organization for persons at high risk of acquiring HIV, but not all countries immediately adopted those recommendations. The South African Medical Research Council (SAMRC) convened a summit to discuss issues relating to SoC and PrEP in HIV prevention clinical trials taking place in lower- to middle-income countries (LMIC). Policymakers, regulators, ethicists, experts in law, researchers, representatives of advocacy groups, and the HIV V...
The choice of suitable study populations in which to conduct large-scale phase III HIV prevention tr...
Introduction Of the two million new HIV infections in adults in 2014, 70% occurred in sub-Saharan Af...
As new HIV prevention tools are developed, researchers face a number of ethical and logistic questio...
Introduction: HIV-prevention and endpoint-driven clinical trials enrol individuals at substantial ri...
Background: Despite increased prevention efforts, HIV remains the leading cause of death among adole...
The Southern African HIV Clinicians Society published its first set of oral pre-exposure prophylaxis...
Introduction Of the two million new HIV infections in adults in 2014, 70% occurred in sub-Saharan Af...
Introduction: Of the two million new HIV infections in adults in 2014, 70% occurred in sub-Saharan A...
HIV prevention trials provide a prevention package to participants to help prevent HIV acquisition. ...
There is an urgent need in sub-Saharan Africa to develop more effective methods of HIV prevention, i...
There is an urgent need in sub-Saharan Africa to develop more effective methods of HIV prevention, i...
Commissioned by SADC Secretariat, JulyIntroduction: Southern Africa is the epicentre of the HIV and ...
Thesis (Ph.D.)--University of Washington, 2021Daily, oral pre-exposure prophylaxis (PrEP) with emtri...
Africa is a crucial setting for preventive HIV clinical trials. We present our experience of setting...
Natasha Mack,1 Stella Kirkendale,1 Paul Omullo,2 Jacob Odhiambo,2 Malebo Ratlhagana,3 Martha Masaki,...
The choice of suitable study populations in which to conduct large-scale phase III HIV prevention tr...
Introduction Of the two million new HIV infections in adults in 2014, 70% occurred in sub-Saharan Af...
As new HIV prevention tools are developed, researchers face a number of ethical and logistic questio...
Introduction: HIV-prevention and endpoint-driven clinical trials enrol individuals at substantial ri...
Background: Despite increased prevention efforts, HIV remains the leading cause of death among adole...
The Southern African HIV Clinicians Society published its first set of oral pre-exposure prophylaxis...
Introduction Of the two million new HIV infections in adults in 2014, 70% occurred in sub-Saharan Af...
Introduction: Of the two million new HIV infections in adults in 2014, 70% occurred in sub-Saharan A...
HIV prevention trials provide a prevention package to participants to help prevent HIV acquisition. ...
There is an urgent need in sub-Saharan Africa to develop more effective methods of HIV prevention, i...
There is an urgent need in sub-Saharan Africa to develop more effective methods of HIV prevention, i...
Commissioned by SADC Secretariat, JulyIntroduction: Southern Africa is the epicentre of the HIV and ...
Thesis (Ph.D.)--University of Washington, 2021Daily, oral pre-exposure prophylaxis (PrEP) with emtri...
Africa is a crucial setting for preventive HIV clinical trials. We present our experience of setting...
Natasha Mack,1 Stella Kirkendale,1 Paul Omullo,2 Jacob Odhiambo,2 Malebo Ratlhagana,3 Martha Masaki,...
The choice of suitable study populations in which to conduct large-scale phase III HIV prevention tr...
Introduction Of the two million new HIV infections in adults in 2014, 70% occurred in sub-Saharan Af...
As new HIV prevention tools are developed, researchers face a number of ethical and logistic questio...